https://www.eventscribe.com/2020/painweek/images/painweek-favicon.ico Full Schedule Skip to main content


Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

Full Schedule

Full Schedule

  • Cancelled
  • 60-Day PNS Treatment May Improve Identification of False-positive and False-negative Responders
  • A Digital Platform to Enable Longitudinal Remote Patient Monitoring Confers a Reduction in Medication Utilization
  • A Long-term Assessment of the Safety, Tolerability, and Durability of an Office-based, Pharmacist-directed Approach to Treatment with Medical Cannabis for Chronic Pain
  • A Needle in a Haystack: OTC Analgesics in Our Opioid Crisis
  • A NEW WEARABLE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICE (ACTITENS®) IS MORE EFFICIENT AND BETTER TOLERATED THAN WEAK OPIOIDS IN THE TREATMENT OF KNEE OSTEOARTHRITIS PAIN. RESULTS OF A RANDOMIZED, CONTROLLED, NON-INFERIORITY TRIAL.
  • A THC/CBD oro-buccal spray with improved mucosal absorption and preliminary efficacy for chronic pain.
  • Abuse and misuse of XTAMPZA® ER relative to other opioid analgesics
  • Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders
  • ALTO-ED: Initiation of a Multidisciplinary SAMSHA Grant Funded Opioid Use Reduction Program in Two Public Health System Emergency Departments
  • Analgesic Combinations in Fixed and Loose Dose
  • Analgesic efficacy and safety of naproxen sodium versus hydrocodone/acetaminophen in acute postsurgical dental pain: a randomized, double-blind, placebo-controlled trial
  • Approved OIC Medication Use in Emergency Department Patients With Opioid-Induced Constipation
  • Assessing Provider Ratings of Satisfaction and Usefulness of the VEGA HCP report – virtual visit
  • At-Home Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial
  • Atogepant 60 mg Once-Daily Shows Efficacy for the Preventive Treatment of Migraine: Results From a 52-Week Open-Label Extension Trial
  • Atypical chest pain in Carpal Tunnel Syndrome: A Case Report
  • Buprenorphine Buccal Film Versus Oral Oxycodone: Effects on Pupillometry and Respiratory Depression in a Phase 1 Placebo-Controlled Trial
  • Buprenorphine Buccal Film Versus Oral Oxycodone: Secondary Respiratory, Pharmacokinetic, and Pupillometry Outcomes From a Phase 1 Placebo-Controlled Trial
  • CBD for the Treatment of Pain, Sleep, and Anxiety: An Interim Analysis of the SELECT Study
  • Characteristics of Patients Significantly Impacted by Migraine Presenting in Primary Care but Not for Migraine: Results of the OVERCOME (US) Study
  • COmbining UbRogepAnt and preventives for miGrainE (COURAGE) study using the Migraine Buddy application: A novel, entirely remote design for collecting real-world evidence
  • Comparison of treatment impact of high concentration capsaicin topical system (QUTENZA®) and oral pregabalin on patient reported outcomes.
  • Complex Dependency in High-Risk Cancer Patients
  • Cryoneurolysis via a Deep Genicular Approach to Reduce Chronic Knee Pain in Osteoarthritis: A Case Series
  • Daily Atogepant for the Preventive Treatment of Migraine Increases Responder Rates for Reduction in Mean Monthly Migraine Days
  • Diagnosis and treatment satisfaction of common pain in urban China: a population-based cross-sectional National Health and Wellness Survey
  • Diversion and street price of XTAMPZA® ER relative to other prescription opioids
  • Economic burden of chronic pain in China
  • Effects of Tolperisone on Driving Performance, Drowsiness, and Cognitive Function: Comparison With Cyclobenzaprine and Placebo in a Phase 1, Randomized, 4-Period, Crossover Study
  • Efficacy of a Mind-Body Intervention on Post-High Intensity Exercise Pain in Patients with Fibromyalgia
  • Enkephalin as a Potential Analgesic and CNS Modulator
  • Evaluating the Impact of Interprofessional Teams to Decrease Opioid Risk in a Veteran Population
  • Evaluation of the impact of oral naloxone for opioid induced constipation on opioid demand and analgesia in trauma surgery patients
  • Exploratory Efficacy of INP104 by Migraine Attack Severity and Time of Dosing: Results From the Phase 3 STOP 301 Study
  • FAMILY BURDEN ASSOCIATED WITH PRESCRIPTION NSAID AND OPIOID TREATMENT IN PATIENTS WITH OSTEOARTHRITIS
  • How to improve pain scores and quality of life in chronic pain patients
  • Impact of Limiting Short-Acting Opioids on Chronic Pain Management in Veterans at VA Loma Linda
  • Improvements in Disability and the Interictal Period with INP104: Results from the Phase 3 STOP 301 Study
  • Is There a Role for Transdermal Buprenorphine to Manage Acute Pain in the Clinical Setting?
  • L-Methylfolate as an Adjunctive Therapy in Diabetic Peripheral Neuropathy
  • Long COVID and Challenges to the Post-Pandemic World
  • Long-term Safety and Tolerability of Atogepant 60 mg Following Once Daily Dosing Over 1 Year for the Preventive Treatment of Migraine
  • Machine Learning Algorithms in Prediction of the Patient Classification with Moderate-to-Severe Osteoarthritis of the Hip and/or Knee and Inadequate/Intolerable Response to Multiple Pain Medications
  • Managing Severe Pain of Hospice Patients on Admission
  • MAT outcomes during COVID19 at rural clinics
  • Medical Cannabis as Adjunctive Treatment for Chronic Non-cancer Pain (CNCP) to Reduce High Opioid Doses & Optimize Pain Control
  • Meloxicam IV for the Management of Pain Following Radiofrequency Ablation (RFA) of the Spine: A Case Study
  • Mental Health Predictors of Response to Standard Medical Treatment in an Active Duty Military Pain Specialty Clinic
  • Naloxegol Provided Rapid and Sustained Improvement of Opioid-Induced Constipation (OIC) Symptoms in Older Adults Age ≥ 65 Yrs: A Pooled Analysis of Two Phase 3 Studies
  • Naloxegol Provided Rapid Onset of Time to First Spontaneous Bowel Movement (SBM), Complete SBM and Predictable Efficacy in Older Adults (Age ≥ 65 Yrs): A Pooled Analysis of Two Phase 3 Studies
  • Naloxegol Provides Rapid and Sustained Improvement of Opioid-Induced Constipation (OIC) Symptoms Irrespective of Opioid Dose: A Pooled Analysis of Two Phase 3 Studies
  • Non-Medical Use and Diversion of XTAMPZA ER in the General Population
  • Novel approach for sacral root stimulation as a treatment for chronic pelvic pain in females
  • Opioid Prescribing Patterns in an Emergency Department at a Veterans Affairs Hospital
  • Opioid Stewardship Really WoRx: Leveraging the Electronic Health Record to Support Safe and Appropriate Opioid Use
  • Pain Catastrophizing in Individuals with Poly-trauma and Chronic Pain: Contribution to Activity Limitations
  • Pain Management Documentation Review of a Long-Term Care Facility
  • Painful diabetic peripheral neuropathy: the impact on the patient
  • Patient Acceptability of INP104 Aligns With the Unmet Needs Identified in the I-BEAM Survey
  • Patient clinical characteristics and treatment utilization among patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibody and novel acute medication
  • Patterns of Prescription Nonsteroidal Anti-Inflammatory Drug (NSAID) Use Among Osteoarthritis Patients in the United States: Real World Evidence
  • Patterns of viral arthropathy / myalgia with the SARS-CoV-2 epidemic
  • Personalized Pain Therapy: An Artificial Intelligence (AI) Method and Web-Tool to Predict Patient Response to OTC Topical Analgesics
  • Pooled Analysis of the Efficacy of Fremanezumab for Reducing Disability and Acute Medication Overuse in Migraine Patients Overusing Migraine-specific Acute Medications at Baseline
  • Presumptive Versus Definitive Drug Testing: What Are We Missing
  • Primary Headache Disorders and Acute Medications Associated With Patients Diagnosed With Medication Overuse Headache: Analysis of US Claims Data
  • Process of the application of Qutenza (Capsaicin 8%) topical patches for diabetic neuropathy
  • Prolotherapy: A Palliative Therapy for Hypermobile Ehlers-Danlos Syndrome
  • Proof of Concept Study Evaluating the Relative Efficacy and Safety of Concomitant Acetaminophen-Naproxen Sodium versus Acetaminophen/Hydrocodone and Naproxen in Postoperative Dental Pain
  • Proposed Risk Stratification of Drug Effect on Inducing Respiratory Depression
  • Prospective, Multicenter Study of Percutaneous Medial Branch PNS for the Treatment of Chronic Axial Low Back Pain
  • Racial variations in healthcare resource use and expenditures in a population of Medicaid patients with knee/hip osteoarthritis
  • Real World Evidence Data from UK to support Treatment with Capsaicin 8% Topical System in Various Peripheral Neuropathic Pain Conditions.
  • Real World Evidence of Sustained Improvements Following Percutaneous PNS: A Retrospective Cross-Sectional Follow-Up Survey of 354 Patients
  • Reasons for Hesitating to Consult for Migraine Care: Results of the OVERCOME (US) Study
  • Repeat Dosing With Subcutaneous Methylnaltrexone: A Pooled Analysis in Patients With and Without Cancer
  • Retrospective Analysis of High concentration Capsaicin Topical System for the treatment of post amputation stump pain and phantom limb pain
  • Retrospective comparison of the effectiveness of buprenorphine versus baclofen for acute opiate withdrawal
  • Risk Stratification of Respiratory Depression With Buprenorphine Buccal Film Versus Oxycodone: Outcomes From a Phase 1 Placebo-Controlled Trial
  • SC Methylnaltrexone in Patients with Advanced Illness and OIC: The Impact of Baseline Laxative Use
  • Skeletal Muscle Spasms and Pain and Dysfunction
  • Suicide by Opioid
  • Sustained Benefits of 10 kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy - 6-Month Randomized Controlled Trial Results
  • Symptoms and diagnosis of painful diabetic peripheral neuropathy: the patient’s experience
  • Termination of effect of long acting injectable naltrexone and related challenges
  • The Association between Opioid Use Disorder and Childhood Adverse Experiences
  • The Body Function, Activity Limitations, and Participation Restrictions of Individuals with Poly-Trauma Clinical Triad
  • The Disparate Definitions and Measures of Post-Operative Respiratory Depression
  • The effectiveness of an Audio-Visual-Stimulation device in managing Fibromyalgia
  • The effectiveness of thermal neuromodulation using precise heat in the treatment of chronic low back pain over 60 days. An in-home user trial.
  • The polysubstance overdose-death crisis
  • The problem of postoperative respiratory depression
  • The use of acupuncture to facilitate goal-setting in chronic pain management
  • Total Pain Burden in Patients With Treatment-resistant Migraine: Effects of Galcanezumab in the CONQUER Phase 3b Trial
  • Treatment of painful diabetic peripheral neuropathy: the patient’s experience
  • Ubrogepant Treatment When Pain Is Mild Increases the Likelihood of Achieving Pain Freedom in Participants Who Treated Migraine Attacks of Mild and Moderate or Severe Pain
  • Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual Migraine Attacks
  • Ultrasound-Guided Dorsal Penile Blocks as an Effective Form of Analgesia for Circumcision
  • Update on In Vivo Testing of NTM-006 (formerly JNJ-10450232), a Novel Orally-Active Non-Opioid Analgesic: CFA and Paw Edema
  • Update on In Vivo Testing of NTM-006 (formerly JNJ-10450232), a Novel Orally-Active Non-Opioid Analgesic: Neuropathic Pain Model
  • What Patients Report Being Discussed During Their Most Recent Visit for Headache in Primary Care: Association with Being Diagnosed with Migraine